1. Home
  2. HNRG vs SLN Comparison

HNRG vs SLN Comparison

Compare HNRG & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HNRG

Hallador Energy Company

HOLD

Current Price

$16.73

Market Cap

743.5M

Sector

Energy

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$13.46

Market Cap

678.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNRG
SLN
Founded
1949
1994
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
743.5M
678.0M
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
HNRG
SLN
Price
$16.73
$13.46
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$25.38
$42.60
AVG Volume (30 Days)
831.0K
1.6M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
116.78
N/A
EPS
N/A
N/A
Revenue
$469,466,000.00
$559,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.09
N/A
52 Week Low
$13.65
$4.19
52 Week High
$24.70
$17.58

Technical Indicators

Market Signals
Indicator
HNRG
SLN
Relative Strength Index (RSI) 56.95 57.67
Support Level $15.22 $13.01
Resistance Level $16.80 $17.58
Average True Range (ATR) 0.83 0.97
MACD 0.15 -0.14
Stochastic Oscillator 91.97 10.95

Price Performance

Historical Comparison
HNRG
SLN

About HNRG Hallador Energy Company

Hallador Energy Co is a vertically integrated, independent power producer (IPP) and fuel company with operations in Indiana. The Company operates across multiple stages of the energy value chain, from accredited capacity and energy to coal. The Company's electric operations are located within the Midcontinent Independent System Operator's (MISO) footprint. The company's business is organized based on the services and products it provide in two segments: (i) Electric Operations and (ii) Coal Operations.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: